Jubilant Cadista Pharmaceuticals, Inc. recalls BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC
Jubilant Cadista recalls 150mg BuPROPion XL tablets with failed dissolution specs. These tablets may not release medication properly. Stop using and contact for details.
Lower-risk recall
Failed Dissolution Specifications; 9-monthstability timepoint
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista is recalling 150mg BuPROPion Hydrochloride Extended-Release Tablets (30-count and 90-count) due to failed dissolution specifications. This means the tablets may not release medication as intended, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/39146-jubilant-cadista-bupropion-xl-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/39146-jubilant-cadista-bupropion-xl-tablets-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-0519-2019
Cite this page
“Jubilant Cadista BuPROPion XL Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39146-jubilant-cadista-bupropion-xl-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0519-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0519-2019%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release medication properly over time. This could lead to inconsistent dosing and reduced effectiveness of the treatment. However, the recall does not indicate immediate safety risks.
Who’s affected
People who have the 150mg BuPROPion XL tablets with NDC 59746-758-30 or 59746-758-90. Those taking this medication for depression or anxiety are most at risk.
How to tell if you have this one
Check for bottles labeled 150mg BuPROPion Hydrochloride Extended-Release Tablets (XL) with NDC numbers 59746-758-30 or 59746-758-90. These were manufactured in India and marketed by Jubilant Cadista in the US.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Stop Using Tablets
Discontinue use of the recalled tablets immediately as they may not release medication properly.
Questions people ask
Are these tablets safe to use?
The recall indicates the tablets failed dissolution specifications, so they may not release medication properly. Do not use these tablets.
What should I do if I have these tablets?
Stop using them immediately and contact Jubilant Cadista for further instructions.
How can I check if my tablets are recalled?
Check the NDC numbers on the bottle: 59746-758-30 or 59746-758-90. These tablets were manufactured in India and marketed by Jubilant Cadista in the US.
Contact Jubilant Cadista
We’ve drafted a message you can send Jubilant Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-0519-2019 — Jubilant Cadista Jubilant Cadista Hello, I own a Jubilant Cadista that is covered by recall D-0519-2019 from Jubilant Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0519-2019 (February 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0519-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.